Chemomab Therapeutics's total assets for Q1 2025 were $12.82M, a decrease of -24.43% from the previous quarter. CMMB total liabilities were $2.43M for the fiscal quarter, a -29.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.